Literature DB >> 7494012

Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis.

J Oksi1, J Uksila, M Marjamäki, J Nikoskelainen, M K Viljanen.   

Abstract

The sensitivities and specificities of three enzyme-linked immunosorbent assays (ELISAs) for Borrelia burgdorferi antibodies were compared for 41 patients presenting with symptoms compatible with late Lyme borreliosis (LB) and 37 healthy controls. All subjects were living in southwestern Finland, where LB is endemic. Only patients with culture- or PCR-proven disease were enrolled in the study. The antigens of the ELISAs consisted of sonicated spirochetes, 41-kDa flagellin, and recombinant P39 protein of B. burgdorferi. Fifteen patients had strongly or moderately positive results in the serological assay(s), 19 patients had only weakly positive or borderline antibody levels, and the remaining 7 patients were seronegative by ELISA. The sensitivities of the ELISAs were 78.0% with sonicate antigen, 41.5% with 41-kDa flagellin, and 14.6% with P39 protein. The specificities of the tests were 89.2, 86.5, and 94.6%, respectively. The sonicate antigen ELISA seems to be an effective screening method. These results show that antibodies to B. burgdorferi may be present in low levels or even absent in patients with culture- or PCR-proven late LB. Therefore, in addition to serological testing, the use of PCR and cultivation is recommended in the diagnosis of LB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494012      PMCID: PMC228390          DOI: 10.1128/jcm.33.9.2260-2264.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Cultivation of Borrelia burgdorferi from the blood and a subcutaneous lesion of a patient with relapsing febrile nodular nonsuppurative panniculitis.

Authors:  M K Viljanen; J Oksi; P Salomaa; M Skurnik; R Peltonen; H Kalimo
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

2.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

Review 3.  Polymerase chain reaction: trenches to benches.

Authors:  D H Persing
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 4.  Lyme disease: recommendations for diagnosis and treatment.

Authors:  D W Rahn; S E Malawista
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

5.  The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene.

Authors:  R Wallich; S E Moter; M M Simon; K Ebnet; A Heiberger; M D Kramer
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.

Authors:  E Fikrig; E D Huguenel; R Berland; D W Rahn; J A Hardin; R A Flavell
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

7.  Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.

Authors:  W J Simpson; W Burgdorfer; M E Schrumpf; R H Karstens; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis.

Authors:  M Karlsson; G Stiernstedt; M Granström; E Asbrink; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

9.  Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi.

Authors:  J Oksi; M K Viljanen; H Kalimo; R Peltonen; R Marttía; P Salomaa; J Nikoskelainen; H Budka; P Halonen
Journal:  Clin Infect Dis       Date:  1993-03       Impact factor: 9.079

10.  Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction.

Authors:  W H Krüger; M Pulz
Journal:  J Med Microbiol       Date:  1991-08       Impact factor: 2.472

View more
  20 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases.

Authors:  M E Bayer; L Zhang; M H Bayer
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

3.  Intracranial aneurysms in three patients with disseminated Lyme borreliosis: cause or chance association?

Authors:  J Oksi; H Kalimo; R J Marttila; M Marjamäki; P Sonninen; J Nikoskelainen; M K Viljanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

4.  Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis.

Authors:  J Panelius; P Lahdenne; H Saxen; T Heikkilä; I Seppälä
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Expression of the bmpB gene of Borrelia burgdorferi is modulated by two distinct transcription termination events.

Authors:  Ramesh Ramamoorthy; Natalie A McClain; Aarti Gautam; Dorothy Scholl-Meeker
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

6.  Improved serodiagnosis of Lyme disease.

Authors:  M M Davidson; S M Chisholm; A D Wiseman; A W Joss; D O Ho-Yen
Journal:  Clin Mol Pathol       Date:  1996-04

7.  Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis.

Authors:  D Roessler; U Hauser; B Wilske
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

8.  Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis.

Authors:  J Oksi; J Savolainen; J Pène; J Bòusquet; P Laippala; M K Viljanen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

9.  Improvement in the laboratory recognition of lyme borreliosis with the combination of culture and PCR methods.

Authors:  Tomasz Chmielewski; Janusz Fiett; Marek Gniadkowski; Stanislawa Tylewska-Wierzbanowska
Journal:  Mol Diagn       Date:  2003

10.  Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.

Authors:  J Oksi; J Nikoskelainen; H Hiekkanen; A Lauhio; M Peltomaa; A Pitkäranta; D Nyman; H Granlund; S-A Carlsson; I Seppälä; V Valtonen; M Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.